The Recall Desk
ModerateFDA (Drugs)·D-0822-2026·Announced 2026-09-09

Bionpharma Recalls Doxylamine Succinate Tablets Due to Foreign Material Presence

Bionpharma Inc. is recalling Doxylamine Succinate and Pyridoxine HCl tablets because foreign tablets or capsules were found in the product.

What this means for you

Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.

Our severity reasoning: The recall is classified as FDA Class III, which indicates a low risk of adverse health consequences, and no specific injuries or illnesses are reported in the source text.

Plain-English summary

Bionpharma Inc. is recalling 14,232 bottles of Doxylamine Succinate and Pyridoxine HCl Delayed-Release tablets (10 mg/10 mg). The recall is due to the presence of foreign tablets or capsules in the product.

The affected product is Lot # DMA25006 with an expiration date of 11/30/2028. The 100-count bottles were distributed nationwide in the United States.

Consumers should stop using the recalled product and contact their healthcare provider or pharmacist for guidance on next steps.

The recalled product

Product
DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE (DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE)
Brand
DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE
Manufacturer
Bionpharma Inc.

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (2)

  • Lot # DMA25006
  • Exp Date: 11/30/2028.

Distribution

Distributed nationwide across the United States.

Same brand · DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE